Anticoagulant Protein S in COVID-19: The Low Activity Level Is Probably Secondary

Am J Ther. 2021 Jan-Feb;28(1):e139-e140. doi: 10.1097/MJT.0000000000001306.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 / blood*
  • COVID-19 / complications
  • Humans
  • Inflammation / blood
  • Inflammation / etiology
  • Lung / pathology
  • Protein S / analysis*
  • Thrombosis / blood

Substances

  • PROS1 protein, human
  • Protein S